Roger S. Lo, MD, PhD Elected to Association of American Physicians (AAP)
Please join us in congratulating UCLA Department of Medicine Professor and Physician Scientist Roger S. Lo, MD, PhD, who was elected to the Association of American Physicians (AAP).
The AAP, established in 1885, is a nonprofit honorary medical society founded by the Canadian physician Sir William Osler and six other distinguished physicians of the same era for “the advancement of scientific and practical medicine.” As the preeminent medical society for physician-scientists, election to the AAP is a significant honor that marks outstanding contributions to basic or translational biomedical research as well as high caliber scientific leadership.
It's no surprise, then, that Dr. Lo was selected to receive this honorific. At UCLA, Dr. Lo is professor of medicine and molecular and medical pharmacology, associate chief of dermatology, and director of the dermatology STAR Residency Program at UCLA’s David Geffen School of Medicine. Dr. Lo has been a Bruin since residency, and joined the UCLA faculty in 2008, received tenure in 2014, and rose to full professor in 2016. In 2013, the American Association for Cancer Research (AACR) recognized Dr. Lo with the 33rd Annual Award for Outstanding Achievement in Cancer Research for providing the major scientific rationale toward the use of BRAF and MEK inhibitors in combination to effectively treat melanoma – a therapeutic approach that is now globally considered the standard of care for melanoma and approved by the US FDA for cancer-agnostic indications for all BRAF V600-mutant cancers.
His laboratory reported the earliest insights on the roles of tumor heterogeneity, genomic instability and the immune microenvironment in determining clinical responses to current melanoma therapies. The group has also provided rationales for multiple clinical trials. Dr. Lo’s AAP election follows a history of impressive honors, including induction into The American Society for Clinical Investigation (ASCI) in 2012, AACR recognition of his translational melanoma research with the inaugural AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research in 2017, and being named a Highly Cited Researcher by ClarivateAnalytics in 2019 and 2021. Dr. Lo is also an inventor on ten patents.
In speaking on the significance of this achievement, Dr. Lo shared, "This election encourages me to double down on translational cancer research and reminds me of my ultimate goal – to use the power of science and technology to generate knowledge that will be critical to improve the care of cancer patients. It also means that there are bigger mountains to climb to achieve a truly meaningful career.” Dr. Lo also emphasized that he sees this achievement as a recognition of his key collaborators at UCLA and worldwide, past and present. "Particularly critical," he shared, "are members of my laboratory and the patients who contribute to our research goals."
Please join us in congratulating Dr. Lo on this extraordinary achievement.
Related Posts
We are pleased to share the news that John Lee, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI). Dr. Lee's membership follows decades[...]
The UCLA Department of Medicine is pleased to announce that Priscilla Hsue, MD will be joining us as the chief of the Division of Cardiology at UCLA,[...]